The clinical curative effect of helicobacter pylori correlation gastritis treated by “Buqi Tuodu Xiaoyong Decoction” combined with triple therapy
|更新时间:2022-08-31
|
The clinical curative effect of helicobacter pylori correlation gastritis treated by “Buqi Tuodu Xiaoyong Decoction” combined with triple therapy
Shanghai Journal of Traditional Chinese MedicineVol. 49, Issue 6, Pages: 39-41(2015)
作者机构:
1. 上海市黄浦区香山中医医院中医内科,上海,200020
作者简介:
基金信息:
DOI:
CLC:
扫 描 看 全 文
SONG Jing, GU Jian-ping, LOU Xiao-meng, et al. The clinical curative effect of helicobacter pylori correlation gastritis treated by “Buqi Tuodu Xiaoyong Decoction” combined with triple therapy. [J]. Shanghai Journal of Traditional Chinese Medicine 49(6):39-41(2015)
DOI:
SONG Jing, GU Jian-ping, LOU Xiao-meng, et al. The clinical curative effect of helicobacter pylori correlation gastritis treated by “Buqi Tuodu Xiaoyong Decoction” combined with triple therapy. [J]. Shanghai Journal of Traditional Chinese Medicine 49(6):39-41(2015)DOI:
The clinical curative effect of helicobacter pylori correlation gastritis treated by “Buqi Tuodu Xiaoyong Decoction” combined with triple therapy
Objective:This paper is to observe the clinical curative effect of helicobacter pylori correlation gastritis treated by “Buqi Tuodu Xiaoyong Decoction” Methods:80 cases of patients with Helicobacter Pylori correlation gastritis were randomly divided into treatment group and control group, and there were 40 cases in each group. The control group treated with standard triple therapy; meanwhile treatment group was given “Buqi Tuodu Xiaoyong Decoction” based on the treatment in control group. The treatment course of the two groups was 14 days with follow-up 6 months. The clinical efficacy, adverse reaction, the change of clinical symptoms, Hp clearance and recurrence were observed during the course Results:① The overall effective rate was 95.00% in the treatment group and 77.50% in the control group, with a difference between the two groups(P<0.05).② Compared before and after the treatment, the difference of the clinical symptoms of TCM in both groups were statistically significant(P<0.05); compared after the treatment of the two groups, the difference of the clinical symptoms of TCM in both groups were statistically significant(P<0.05).③ Hp clearance of the treatment group was 90.00% and 72.50% in the control group, with a difference between the two groups(P<0.05).④ During the follow-up period, there were 2 cases of recurrence(5.56%) in the treatment group and 6 cases (20.69%) in the control group, with a difference between the two groups(P<0.05). ⑤No significant difference was found in adverse reaction between the two groups (P>0.05) Conclusion:Helicobacter Pylori correlation gastritis treated by “Buqi Tuodu Xiaoyong Decoction” combined with triple therapy can get high Hp clearance and low recurrence.
Wang Jianyi's experience in treating gastric distention with Liuwei Xiaopi Prescription
Prevention and treatment of inflammation⁃cancer transformation of chronic gastritis from the perspective of holistic integrative medicine
Analysis on the distribution of chronic gastritis in TCM syndromes and Helicobacter pylori infection
Shen Xiaoheng’s experience on the herbal treatment of chronic gastritis
Record of chronic colitis complicated with intestinal polyps in teaching ward round
Related Author
No data
Related Institution
Department of Hepatology, Yueyang Hospital of Integrated Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Dongzhimen Hospital, Beijing University of Chinese Medicine
College of Traditional Chinese Medicine, Beijing University of Chinese Medicine
Department of Oncology,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Cancer Institute of Integrated Chinese and Western Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine